Irulya Therapeutics (IRLA) traded up 0.76 % during a 24 hours period ending at 06:37 PM Central Europe on Monday 26th. One Irulya Therapeutics stock can currently be bought for about USD 30.95 on popular exchanges. Current supply of Irulya Therapeutics stocks is 1 mn. Irulya Therapeutics has a current market capitalization of USD 33.6 mn and approximately USD 3 mn worth of Irulya Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Irulya Therapeutics has traded 10.27 % up. Simple moving average of last 200 days is at USD 68. The highest price of past 52 weeks was recorded at USD 910 on 12/12/2025. 52 weeks low was at USD 15.1 on 07/01/2026.
Here is how related stocks have performed in the past 24 hours:
Southland (SLND) traded up 1.23 % and now trades at USD 0.76. Southland has a market capitalisation of USD 40.3 mn.
Instil Bio (TIL) traded up 2.46 % and now trades at USD 5.67. Instil Bio has a market capitalisation of USD 39.6 mn.
Massimo (MAMO) traded down -0.73 % and now trades at USD 0.92. Current market capitalisation for Massimo is USD 39.6 mn.
Cerenome (CNSY) traded up 22.45 % and now trades at USD 1.7. Cerenome has a market capitalisation of USD 39.3 mn.
Xtant Medical (XTNT) traded down -9.68 % and now trades at USD 0.29. Current market capitalisation for Xtant Medical is USD 39.6 mn.
About Irulya Therapeutics
Quince Therapeutics, Inc. is a biopharmaceutical company that specializes in developing precision therapeutics. These therapeutics are designed to deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote faster healing with fewer off-target safety concerns. The company operates in the health care sector and serves its customers in the United States. You can find more information about their work on their website, www.quincetx.com , and they are listed on the Nasdaq stock exchange.
